Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biotin-Labeled Red Blood Cells for Evaluation of Genetic Factors in RBC Storage
NCT03364686Phase 2Terminated
- Start
- Sep 2019
- Primary completion
- Mar 2021
- Modality
- Recombinant Proteins and Enzymes, Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of Biotinylated red blood cell. Started Sep 2019; status: terminated.
02
Drugs
Biotinylated red blood cell
Beyond the preview
Go deeper on NCT03364686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03364686.